Literature DB >> 16322279

Liposomal, nanoparticle, and conjugated formulations of anticancer agents.

William C Zamboni1.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16322279     DOI： 10.1158/1078-0432.CCR-05-1895

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  57 in total

Review 1.  Best practices in cancer nanotechnology: perspective from NCI nanotechnology alliance.

Authors:  William C Zamboni; Vladimir Torchilin; Anil K Patri; Jeff Hrkach; Stephen Stern; Robert Lee; Andre Nel; Nicholas J Panaro; Piotr Grodzinski
Journal:  Clin Cancer Res       Date:  2012-06-05       Impact factor: 12.531

2.  Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy.

Authors:  Chao Liang; Baosheng Guo; Heng Wu; Ningsheng Shao; Defang Li; Jin Liu; Lei Dang; Cheng Wang; Hui Li; Shaohua Li; Wing Ki Lau; Yu Cao; Zhijun Yang; Cheng Lu; Xiaojuan He; D W T Au; Xiaohua Pan; Bao-Ting Zhang; Changwei Lu; Hongqi Zhang; Kinman Yue; Airong Qian; Peng Shang; Jiake Xu; Lianbo Xiao; Zhaoxiang Bian; Weihong Tan; Zicai Liang; Fuchu He; Lingqiang Zhang; Aiping Lu; Ge Zhang
Journal:  Nat Med       Date:  2015-02-09       Impact factor: 53.440

Review 3.  Nanotechnology and cancer.

Authors:  James R Heath; Mark E Davis
Journal:  Annu Rev Med       Date:  2008       Impact factor: 13.739

4.  Development of a novel method for formulating stable siRNA-loaded lipid particles for in vivo use.

Authors:  Sherry Y Wu; Lisa N Putral; Mingtao Liang; Hsin-I Chang; Nigel M Davies; Nigel A J McMillan
Journal:  Pharm Res       Date:  2008-11-21       Impact factor: 4.200

5.  In vitro and in vivo evaluation of lipofufol, a new triple stealth liposomal formulation of modulated 5-fu: impact on efficacy and toxicity.

Authors:  Raphaelle Fanciullino; Séverine Mollard; Sarah Giacometti; Yael Berda-Haddad; Mohamed Chefrour; Claude Aubert; Athanassios Iliadis; Joseph Ciccolini
Journal:  Pharm Res       Date:  2013-02-06       Impact factor: 4.200

Review 6.  Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy.

Authors:  Srinivas Ramishetti; Leaf Huang
Journal:  Ther Deliv       Date:  2012-12

7.  Translational studies of phenotypic probes for the mononuclear phagocyte system and liposomal pharmacology.

Authors:  Whitney P Caron; John C Lay; Alan M Fong; Ninh M La-Beck; Parag Kumar; Suzanne E Newman; Haibo Zhou; Jane H Monaco; Daniel L Clarke-Pearson; Wendy R Brewster; Linda Van Le; Victoria L Bae-Jump; Paola A Gehrig; William C Zamboni
Journal:  J Pharmacol Exp Ther       Date:  2013-09-16       Impact factor: 4.030

8.  Odyssey of a cancer nanoparticle: from injection site to site of action.

Authors:  Joseph W Nichols; You Han Bae
Journal:  Nano Today       Date:  2012-12-01       Impact factor: 20.722

9.  Design and evaluation of liposomal formulation of pilocarpine nitrate.

Authors:  S Rathod; S G Deshpande
Journal:  Indian J Pharm Sci       Date:  2010-03       Impact factor: 0.975

10.  A simple way to enhance Doxil® therapy: drug release from liposomes at the tumor site by amphiphilic block copolymer.

Authors:  Yi Zhao; Daria Y Alakhova; Jong Oh Kim; Tatiana K Bronich; Alexander V Kabanov
Journal:  J Control Release       Date:  2013-03-06       Impact factor: 9.776
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.